ICA Funded Scientist Ronit Satchi-Fainaro’s Research Yields a Breakthrough in Treating Glioblastomas
A new study funded by the Israel Cancer Association, the European Research Council (ERC) and the Kahn foundation, conducted by Prof. Ronit Satchi-Fainaro, Chair of the Department of Physiology and Pharmacology at the Sackler Faculty of Medicine, Head of the Cancer Angiogenesis and Nanomedicine Laboratory in Tel Aviv University, led to a breakthrough in glioblastoma research.
For 60 years, Israel Cancer Association (ICA) has been making a dramatic difference in the lives of individuals touched by cancer. By providing major funding to brilliant cancer scientists in the State of Israel, ICA has advanced cancer research worldwide. Please join in our mission to support innovative cancer breakthroughs. Together we can fund a cure!